Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients

Figure 2

(a) The percentage of CIK cells including (CD3+ CD56+), (CD3+ CD56−), and (CD3− CD56+) before and after induction and CD4+ and CD8+ before and after induction in one of the patients. (b) The percentage of NK cells (CD3+ CD56−) before and after induction and the activated NK (CD56+ CD69+) before and after induction in one of the patients. (c) The percentage of γδT before and after induction in one of the patients.

(a)

(b)

(c)